Trials / Not Yet Recruiting
Not Yet RecruitingNCT06398145
D-chiro-inositol and AUB
The Use of D-chiro-inositol in the Treatment of AUB
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University Of Perugia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Patients with AUB will undergo 6-month treatment with D-chiro-inositol and will fill in questionnaires on AUB, with the evaluation of hormonal serum levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | D-chiro-inositol and lactalbumin (high dose) | From 0 to 3 months: 1200mg D-chiro-inositol and 120mg lactalbumin per day |
| DIETARY_SUPPLEMENT | D-chiro-inositol and lactalbumin (low dose) | From 3 to 6 months: 600mg D-chiro-inositol and 60mg lactalbumin per day |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-06-01
- Completion
- 2025-07-01
- First posted
- 2024-05-03
- Last updated
- 2024-05-03
Source: ClinicalTrials.gov record NCT06398145. Inclusion in this directory is not an endorsement.